Anti-PI3 Kinase p110 beta antibody [Y384]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
5
(1 Review)
|
(20 Publications)
Rabbit Recombinant Monoclonal PI3 Kinase p110 beta antibody. Suitable for IP, WB and reacts with Human samples. Cited in 20 publications.
View Alternative Names
PIK3C1, PIK3CB, PI3-kinase subunit beta, PI3K-beta, PI3Kbeta, PtdIns-3-kinase subunit beta, Serine/threonine protein kinase PIK3CB, PtdIns-3-kinase subunit p110-beta, p110beta
- IP
Lab
Immunoprecipitation - Anti-PI3 Kinase p110 beta antibody [Y384] (AB32569)
PI3 Kinase p110 beta was immunoprecipitated from 0.35 mg Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate 10 µg with ab32569 at 1/50 dilution (2µg). VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate 10 µg
Lane 2 : ab32569 IP in Jurkat whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab32569 in Jurkat whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-PI3 Kinase p110 beta antibody [Y384] (ab32569)
Predicted band size: 123 kDa
Observed band size: 110 kDa
false
- WB
Lab
Western blot - Anti-PI3 Kinase p110 beta antibody [Y384] (AB32569)
Lane 1 : Wild-type HAP1 cell lysate (40 μg)
Lane 2 : PI3 Kinase p110 beta knockout HAP1 cell lysate (40 μg)
Lane 3 : Jurkat cell lysate (40 μg)
Lane 4 : K562 cell lysate (40 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab32569 observed at 125 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab32569 was shown to recognize PI3 Kinase p110 beta when PI3 Kinase p110 beta knockout samples were used, along with additional cross-reactive bands. Wild-type and PI3 Kinase p110 beta knockout samples were subjected to SDS-PAGE. ab32569 and ab8245 (loading control to GAPDH) were diluted at 1/500 and 1/10,000 dilution respectively and incubated overnight at 4C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PI3 Kinase p110 beta antibody [Y384] (ab32569)
Predicted band size: 123 kDa
false
- WB
Unknown
Western blot - Anti-PI3 Kinase p110 beta antibody [Y384] (AB32569)
All lanes:
Western blot - Anti-PI3 Kinase p110 beta antibody [Y384] (ab32569) at 1/500 dilution
All lanes:
Jurkat cell lysate
Predicted band size: 123 kDa
Observed band size: 110 kDa
false
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PI3 kinase p110β plays a role in the regulation of cellular processes such as proliferation migration and metabolism. It is a component of the PI3K complex comprised of regulatory and catalytic subunits which form functional homodimers or heterodimers. This complex is activated by various receptors including G-protein coupled receptors (GPCRs) and tyrosine kinase receptors. By converting PIP2 to PIP3 it aids in the recruitment and activation of downstream signaling proteins like AKT.
Pathways
PI3 kinase p110β is integral in the PI3K/AKT signaling pathway and also contributes to the regulation of the mTOR pathway. These pathways are critical for controlling cellular responses to growth signals and maintaining homeostasis. Association with proteins like PTEN which negatively regulates the PI3K/AKT pathway highlights its importance in maintaining cellular balance. PI3 kinase p110β also interacts with other PI3 proteins like p110α showing the intricate network of signaling it participates in.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (20)
Recent publications for all applications. Explore the full list and refine your search
Thoracic cancer 16:e15485 PubMed39552193
2024
Applications
Unspecified application
Species
Unspecified reactive species
Tissue engineering and regenerative medicine 19:1251-1266 PubMed36042130
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 13: PubMed34830882
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:720925 PubMed34790657
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 11:15761 PubMed34344927
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 44:1333-1342 PubMed32945504
2020
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunology (Baltimore, Md. : 1950) 203:137-147 PubMed31092639
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 15:1829-1838 PubMed29399196
2018
Applications
Unspecified application
Species
Unspecified reactive species
Medical science monitor : international medical jo 24:623-635 PubMed29384143
2018
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 14:1967-1974 PubMed28962111
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com